Vor Biopharma Inc
NASDAQ:VOR
Cash Flow Statement
Cash Flow Statement
Vor Biopharma Inc
Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||||||||||
Net Income |
(19)
|
(23)
|
(32)
|
(43)
|
(49)
|
(60)
|
(66)
|
(69)
|
(78)
|
(81)
|
(86)
|
(92)
|
(98)
|
(106)
|
(116)
|
(118)
|
(120)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
4
|
|
Stock-Based Compensation |
0
|
0
|
1
|
1
|
2
|
3
|
4
|
4
|
5
|
6
|
8
|
11
|
13
|
16
|
15
|
13
|
0
|
|
Other Non-Cash Items |
1
|
1
|
1
|
2
|
3
|
5
|
6
|
7
|
9
|
10
|
13
|
17
|
19
|
19
|
17
|
13
|
12
|
|
Change in Working Capital |
2
|
(0)
|
2
|
4
|
(3)
|
(3)
|
(6)
|
(9)
|
(7)
|
(13)
|
(13)
|
(13)
|
(11)
|
(2)
|
0
|
1
|
(2)
|
|
Cash from Operating Activities |
(16)
N/A
|
(23)
-45%
|
(28)
-23%
|
(36)
-28%
|
(48)
-32%
|
(56)
-17%
|
(65)
-16%
|
(69)
-6%
|
(74)
-8%
|
(83)
-11%
|
(84)
-2%
|
(85)
-1%
|
(87)
-2%
|
(86)
+1%
|
(95)
-11%
|
(100)
-6%
|
(106)
-6%
|
|
Investing Cash Flow | ||||||||||||||||||
Capital Expenditures |
(1)
|
(2)
|
(3)
|
(4)
|
(5)
|
(5)
|
(4)
|
(4)
|
(5)
|
(10)
|
(9)
|
(8)
|
(7)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
Other Items |
0
|
0
|
0
|
0
|
0
|
(75)
|
(83)
|
(88)
|
(93)
|
(15)
|
6
|
(86)
|
(74)
|
(63)
|
(35)
|
72
|
110
|
|
Cash from Investing Activities |
(1)
N/A
|
(2)
-27%
|
(3)
-68%
|
(4)
-50%
|
(5)
-15%
|
(80)
-1 579%
|
(87)
-9%
|
(92)
-5%
|
(98)
-6%
|
(24)
+75%
|
(3)
+88%
|
(94)
-3 036%
|
(81)
+14%
|
(64)
+20%
|
(36)
+43%
|
71
N/A
|
108
+53%
|
|
Financing Cash Flow | ||||||||||||||||||
Net Issuance of Common Stock |
35
|
82
|
82
|
83
|
299
|
235
|
235
|
235
|
1
|
1
|
5
|
117
|
120
|
120
|
116
|
4
|
1
|
|
Other |
0
|
0
|
0
|
0
|
(2)
|
(2)
|
(2)
|
(2)
|
(0)
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
|
Cash from Financing Activities |
35
N/A
|
82
+131%
|
82
+1%
|
83
+0%
|
298
+261%
|
233
-22%
|
233
0%
|
233
+0%
|
0
-100%
|
1
+404%
|
5
+296%
|
117
+2 157%
|
119
+2%
|
119
0%
|
115
-3%
|
3
-97%
|
1
-83%
|
|
Change in Cash | ||||||||||||||||||
Net Change in Cash |
18
N/A
|
57
+214%
|
51
-10%
|
42
-18%
|
245
+482%
|
97
-61%
|
80
-17%
|
72
-10%
|
(172)
N/A
|
(106)
+38%
|
(82)
+22%
|
(62)
+24%
|
(48)
+23%
|
(31)
+35%
|
(16)
+49%
|
(26)
-67%
|
3
N/A
|
|
Free Cash Flow | ||||||||||||||||||
Free Cash Flow |
(17)
N/A
|
(25)
-43%
|
(31)
-26%
|
(40)
-30%
|
(53)
-30%
|
(61)
-16%
|
(69)
-13%
|
(73)
-5%
|
(79)
-8%
|
(92)
-17%
|
(94)
-1%
|
(94)
+0%
|
(93)
+1%
|
(87)
+7%
|
(96)
-11%
|
(101)
-6%
|
(108)
-6%
|